Does a treatment for pelvic congestion syndrome affect future fertility? A study measuring hormone levels before and after ovarian vein embolization

Prospective evaluation of reproductive safety after ovarian vein embolization for pelvic congestion syndrome using anti-Müllerian hormone levels

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17249800

Enrollment

Registered

2026-04-09

Start date

2023-04-06

Completion date

Unknown

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic congestion syndrome (chronic pelvic pain of venous origin) Urological and Genital Diseases

Interventions

All patients underwent ovarian vein embolization for the treatment of pelvic congestion syndrome using standard interventional radiology techniques. The procedure was performed via femoral venous acce

Eligibility

Sex/Gender

Female

Age

21 Years to 45 Years

Inclusion criteria

Inclusion criteria: Female patients aged 21–45 years with a diagnosis of pelvic congestion syndrome and an established indication for ovarian vein embolization

Exclusion criteria

Exclusion criteria: 1. History of ovarian surgery 2. Prior oophorectomy 3. Age outside 21–45 years

Countries

Türkiye

Contacts

Public ContactAli Dablan

ali.dablan@saglik.gov.tr+90 5389230101

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 23, 2026